ArticleOncotarget2019

Correction: PARP-1 inhibitor modulate β-catenin signaling to enhance cisplatin sensitivity in cancer cervix.

Minakshi Mann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.